However, patients treated with C7R-GD2.CARTs exhibited a higher proportion of tumor-specific polyfunctional cells as well as circulating IFN-γ and granzyme B levels, which have been associated with improved tumor killing by T cells.27 This evidence concerns the gene GZMB and neoplasm.